WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laurent HumeauChief Scientific Officer2026-05-202,163$1.23
$2.66kSell
Jacqueline Elizabeth SheaChief Executive Officer2026-05-2012,306$1.23
$15.14kSell
Michael John SumnerChief Medical Officer2026-05-202,693$1.23
$3.31kSell
Peter KiesCFO2026-05-204,688$1.23
$5.77kSell
Laurent HumeauChief Scientific Officer2026-05-151,712$1.30
$2.23kSell
Jacqueline Elizabeth SheaChief Executive Officer2026-05-157,717$1.30
$10.03kSell
Peter KiesCFO2026-05-152,571$1.30
$3.34kSell
Michael John SumnerChief Medical Officer2026-05-15680$1.30
$884.00Sell
Michael John SumnerChief Medical Officer2026-03-311,223$1.74
$2.13kSell
Jacqueline Elizabeth SheaChief Executive Officer2026-02-268,057$1.79
$14.42kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe25.10%20,650,987$13.79MInsider
Fmr LLC11.35%9,339,614$6.24MInstitution
Tee Khiang Ng5.96%4,899,931$3.27MInsider
Janus Henderson Group PLC4.02%3,308,406$2.21MInstitution
Vanguard Capital Management LLC3.53%2,901,208$1.94MInstitution
Boxer Capital Management LLC2.88%2,370,122$1.58MInstitution
Jong Joseph Kim2.85%2,346,000$1.57MInsider
D E Shaw Co Inc2.69%2,212,819$1.48MInstitution
Adar1 Capital Management LLC1.79%1,470,108$982.03kInstitution
Millennium Management LLC1.71%1,410,845$942.44kInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO38.12%37.87%Net SellingNet Selling
XLO7.00%93.00%Net Selling
INKT0.52%99.48%Net BuyingNet Buying
DOMH7.11%67.28%Net Selling
INMB20.23%27.96%Net BuyingNet Buying
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 38.12% institutional shareholders, 37.87% Inovio Pharmaceuticals insiders, and 24.01% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 25.10% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $13.79M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.